LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Radicicol | 1.11 | uM | LJP5 | 3 | K09 | 72 | hr | 1334 | 945 | 4117 | 0.2295 | -0.1914 |
| BT-20 | Radicicol | 3.33 | uM | LJP6 | 1 | K08 | 72 | hr | 1334 | 1038 | 3955 | 0.2624 | -0.1482 |
| BT-20 | Radicicol | 3.33 | uM | LJP6 | 2 | K08 | 72 | hr | 1334 | 988 | 3899 | 0.2534 | -0.1767 |
| BT-20 | Radicicol | 3.33 | uM | LJP6 | 3 | K08 | 72 | hr | 1334 | 916 | 3921 | 0.2336 | -0.2150 |
| BT-20 | Radicicol | 3.33 | uM | LJP5 | 1 | K08 | 72 | hr | 1334 | 958 | 3930 | 0.2437 | -0.1917 |
| BT-20 | Radicicol | 3.33 | uM | LJP5 | 2 | K08 | 72 | hr | 1334 | 964 | 4051 | 0.2380 | -0.1838 |
| BT-20 | Radicicol | 3.33 | uM | LJP5 | 3 | K08 | 72 | hr | 1334 | 941 | 4117 | 0.2285 | -0.1935 |
| BT-20 | Radicicol | 10 | uM | LJP6 | 1 | K07 | 72 | hr | 1334 | 982 | 3955 | 0.2482 | -0.1778 |
| BT-20 | Radicicol | 10 | uM | LJP6 | 2 | K07 | 72 | hr | 1334 | 998 | 3899 | 0.2560 | -0.1713 |
| BT-20 | Radicicol | 10 | uM | LJP6 | 3 | K07 | 72 | hr | 1334 | 970 | 3921 | 0.2474 | -0.1856 |
| BT-20 | Radicicol | 10 | uM | LJP5 | 1 | K07 | 72 | hr | 1334 | 967 | 3930 | 0.2460 | -0.1868 |
| BT-20 | Radicicol | 10 | uM | LJP5 | 2 | K07 | 72 | hr | 1334 | 961 | 4051 | 0.2372 | -0.1854 |
| BT-20 | Radicicol | 10 | uM | LJP5 | 3 | K07 | 72 | hr | 1334 | 974 | 4117 | 0.2365 | -0.1762 |
| BT-20 | Withaferin A | 0.04 | uM | LJP6 | 1 | G18 | 72 | hr | 1334 | 3772 | 3955 | 0.9535 | 0.9402 |
| BT-20 | Withaferin A | 0.04 | uM | LJP6 | 2 | G18 | 72 | hr | 1334 | 4075 | 3899 | 1.0451 | 1.0579 |
| BT-20 | Withaferin A | 0.04 | uM | LJP6 | 3 | G18 | 72 | hr | 1334 | 3932 | 3921 | 1.0027 | 1.0035 |
| BT-20 | Withaferin A | 0.04 | uM | LJP5 | 1 | G18 | 72 | hr | 1334 | 3828 | 3930 | 0.9739 | 0.9663 |
| BT-20 | Withaferin A | 0.04 | uM | LJP5 | 2 | G18 | 72 | hr | 1334 | 4113 | 4051 | 1.0153 | 1.0190 |
| BT-20 | Withaferin A | 0.04 | uM | LJP5 | 3 | G18 | 72 | hr | 1334 | 4201 | 4117 | 1.0202 | 1.0248 |
| BT-20 | Withaferin A | 0.12 | uM | LJP6 | 1 | G17 | 72 | hr | 1334 | 3997 | 3955 | 1.0104 | 1.0133 |
| BT-20 | Withaferin A | 0.12 | uM | LJP6 | 2 | G17 | 72 | hr | 1334 | 4260 | 3899 | 1.0925 | 1.1178 |
| BT-20 | Withaferin A | 0.12 | uM | LJP6 | 3 | G17 | 72 | hr | 1334 | 3882 | 3921 | 0.9900 | 0.9871 |
| BT-20 | Withaferin A | 0.12 | uM | LJP5 | 1 | G17 | 72 | hr | 1334 | 3214 | 3930 | 0.8177 | 0.7576 |
| BT-20 | Withaferin A | 0.12 | uM | LJP5 | 2 | G17 | 72 | hr | 1334 | 3807 | 4051 | 0.9398 | 0.9239 |
| BT-20 | Withaferin A | 0.12 | uM | LJP5 | 3 | G17 | 72 | hr | 1334 | 3800 | 4117 | 0.9229 | 0.9036 |